Catalyst Wire Dossier Catalyst Wire Dossier

ciclesonide HFA nasal aerosol

ciclesonide · Sumitomo Pharma America, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ciclesonide HFA nasal aerosol, covering 2012-06-08 to 2022-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422) [Phase 4]

See pricing